Novartis to cut up to 8,000 jobs 

The pharmaceutical giant, which employs 1,500 people across three locations in Cork and Dublin, will kick off a restructuring programme over the coming months 

The plan involves integrating the company's pharmaceuticals and oncology business units, eliminating over 1,000 roles at its Basel base. Around 6,600 more jobs are at risk globally.

Novartis could cut nearly 8,000 jobs, or 7.4% of its global workforce, as part of a major restructuring programme.

The Swiss pharmaceutical giant, which employs 1,500 people across three locations in Cork and Dublin, first announced the cuts in April but more details of the plans have emerged this week.